Lonza Amaxa 4D-Nucleofector system

Monday, 02 August, 2010 | Supplied by: Capsugel Australia Pty Ltd

Lonza Amaxa 4D-Nucleofector system

The Amaxa Nucleofector technology is claimed to be the first efficient non-viral transfection method for primary cells and hard-to-transfect cell lines.

With a new platform, the 4D-Nucleofector system enables nucleofection of cells in several formats, combined with good performance and convenience.

Its features include: transfection of variable cell numbers with same conditions; choice of throughputs from 1 to 16 wells in just 10 s; nucleofection of adherent cells for functional assays at various cellular stages.

The modular system will accommodate upcoming transfection challenges and a current transfection protocol database is available with 690 cells listed, which is continuously updated.

Online: lonzabioscience.com.au
Phone: 1300 657508
Related Products

Bio-Rad Laboratories ddPLEX ESR1 Mutation Detection Kit

The kit enables simultaneous detection, discrimination and absolute quantification of seven known...

AdipoGen Life Sciences InVivoKines recombinant fusion proteins

InVivoKines are recombinant fusion proteins for immunotherapeutic, preclinical and translational...

EpigenTek MethylFlash 5-mC RNA Methylation ELISA Easy Kit (Fluorometric)

EpigenTek's MethylFlash 5-mC RNA Methylation ELISA Easy Kit (Fluorometric) is a complete set...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd